CIPLA's weekly return of 0.98% was modest, but its volatility of 21.1% suggests a relatively stable performance. Compared to its peers, CIPLA underperformed SUNPHARMA and DIVISLAB, but outperformed GRASIM. With a Sharpe Ratio of 0.19, the stock's risk-adjusted return was relatively low, indicating a moderate level of risk. Overall, CIPLA's performance was lackluster, but its volatility was in line with the industry average.

[Volatility: 21.1%]